Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Accountprinceon Apr 10, 2023 5:47pm
144 Views
Post# 35387469

RE:RE:RE:I thought…

RE:RE:RE:I thought…Unfortunately I was not able to attend the presentation last Thursday due to holiday family commitments.  I have just read the presentation and my take is as follows:

If you're an optimist you will accept everything that management has said.

If you're a pessimist you'll reject everything that management has said.

If you're a pragmatist you realize that this management team is the one that's going to get us across the finish line - I don't see any signs the BOD are planning any changes to the team and they are in control.  The Team's timing to date is unimpressive but the result is solid for the 35% achieved so far.  Economics still very good - even if only a 30% penetration of the addressable market that's $185 million USD at minimum 10 times at conversion rate of 1.35 and using 350 million shares that's still above $7 Cdn a share.  I gather valuation metrics quoted during the presentation session by management were several times that result.

So being a pragmatist I resign myself to the new time frame with continuing and close scrutiny of management and their work.  I will cheer true achievements but call out continuing failures.  I'd love to be in the position of only cheering.
<< Previous
Bullboard Posts
Next >>